results
Jump to
10 Results Found
  • Indoco Remedies Q3 PAT seen up 191.2% YoY to Rs. 9.3 cr: Prabhudas Lilladher Jan 18, 2021 11:11 PM IST

    Indoco Remedies Q3 PAT seen up 191.2% YoY to Rs. 9.3 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 17.7 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 283.4 crore, according to Prabhudas Lilladher.

  • Indoco Remedies Q1 PAT may dip 180.3% YoY to Rs. 9.6 cr: Prabhudas Lilladher Jul 12, 2019 05:06 PM IST

    Indoco Remedies Q1 PAT may dip 180.3% YoY to Rs. 9.6 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 26.2 percent Y-o-Y (up 9.5 percent Q-o-Q) to Rs. 268.2 crore, according to Prabhudas Lilladher.

  • Indoco Remedies Q2 PAT may dip 42.5% YoY to Rs. 11.4 cr: ICICI Direct Oct 12, 2018 04:54 PM IST

    Indoco Remedies Q2 PAT may dip 42.5% YoY to Rs. 11.4 cr: ICICI Direct

    Net Sales are expected to decrease by 7.7 percent Y-o-Y (up 20.9 percent Q-o-Q) to Rs. 262.9 crore, according to ICICI Direct.

  • Indoco Remedies Q1 PAT may dip 24.24% YoY to Rs 15 cr: KR Choksey Jul 18, 2017 06:49 PM IST

    Indoco Remedies Q1 PAT may dip 24.24% YoY to Rs 15 cr: KR Choksey

    Net Sales are expected to increase by 0.41 percent Q-o-Q (up 5.54 percent Y-o-Y) to Rs 266.7 crore, according to KR Choksey. Indoco Remedies to report net profit at 15 crore down 24.24% year-on-year.

  • Indoco Remedies Q3 PAT seen up 3.4% to Rs 22.9 cr: KR Choksey Jan 13, 2017 12:49 PM IST

    Indoco Remedies Q3 PAT seen up 3.4% to Rs 22.9 cr: KR Choksey

    Net Sales are expected to increase by 5.3 percent Q-o-Q (up 14.5 percent Y-o-Y) to Rs 296 crore, according to KR Choksey.

  • Pharma companies revenues to rise 12% in Q3: Anand Rathi Jan 03, 2014 05:34 PM IST

    Pharma companies revenues to rise 12% in Q3: Anand Rathi

    Pharma companies are likely to post 12 percent Y-o-Y revenue growth. However, excluding Wockhardt (FDA issues) and Fortis Healthcare (divestments), revenue growth is expected to be 19 percent Y-o-Y.

  • See pharma sector's margins to dip 314 bps in 3QFY13: Angel Jan 08, 2013 05:10 PM IST

    See pharma sector's margins to dip 314 bps in 3QFY13: Angel

    Angel Broking has come out with earning expectations for pharmaceutical sector for the October-December quarter of 2012. The research firm expects the Indian pharma sector to post lackluster numbers for 3QFY2013 on the sales front.

  • Indoco Remedies Sept qtr PAT seen up at Rs 18cr: Angel Oct 08, 2011 12:05 PM IST

    Indoco Remedies Sept qtr PAT seen up at Rs 18cr: Angel

    Angel Broking has come out with its earning estimates on pharma sector for the quarter ended September 2011. According to the research firm, Indoco Remedies September quarter net sales are expected to go up by 12% at Rs 148 crore, year-on-year, (YoY) basis.

  • Indoco Remedies Dec qtr PAT seen up 60% at Rs 12.4cr: Angel Jan 15, 2011 10:19 AM IST

    Indoco Remedies Dec qtr PAT seen up 60% at Rs 12.4cr: Angel

    Angel Broking has come out with its earning estimates on the pharmaceutical sector for the quarter ended December 2010. According to the research firm, Indoco Remedies December quarter net sales are expected to go up by 27.2% to Rs 122 crore, Year-on-Year, (Y-o-Y) basis.

  • Indoco Remedies Dec qtr PAT seen up at Rs 12.9cr: Karvy Jan 12, 2011 04:42 PM IST

    Indoco Remedies Dec qtr PAT seen up at Rs 12.9cr: Karvy

    Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Indoco Remedies December quarter sales are expected to go up by 28.8% at Rs 123.6 crore, Year-on-Year, (YoY) basis.

Sections